Stoke Therapeutics, Inc. (STOK)
29.14
-0.14
(-0.48%)
USD |
NASDAQ |
Jan 16, 10:37
Stoke Therapeutics SG&A Expense (TTM): 58.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.431B |
| Insmed, Inc. | 631.20M |
| Pfizer Inc. | 13.91B |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Mirum Pharmaceuticals, Inc. | 239.73M |